Paolo G Camici
Overview
Explore the profile of Paolo G Camici including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
267
Citations
8806
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ranasinghe S, Merz C, Khan N, Wei J, George M, Berry C, et al.
J Clin Med
. 2023 Sep;
12(17).
PMID: 37685713
Women with obstructive coronary artery disease (CAD) have a relatively lower quality of life (QoL) compared to men, but our understanding of sex differences in QoL in ischemia with no...
12.
Ammirati E, Lupi L, Palazzini M, Ciabatti M, Rossi V, Gentile P, et al.
Circ Heart Fail
. 2023 May;
16(6):e010315.
PMID: 37183708
No abstract available.
13.
Schindler T, Fearon W, Pelletier-Galarneau M, Ambrosio G, Sechtem U, Ruddy T, et al.
JACC Cardiovasc Imaging
. 2023 Mar;
16(4):536-548.
PMID: 36881418
Angina pectoris and dyspnea in patients with normal or nonobstructive coronary vessels remains a diagnostic challenge. Invasive coronary angiography may identify up to 60% of patients with nonobstructive coronary artery...
14.
Updates on MINOCA and INOCA through the 2022 publications in the International Journal of Cardiology
Pelliccia F, Camici P
Int J Cardiol
. 2023 Jan;
374:8-11.
PMID: 36649889
No abstract available.
15.
Pelliccia F, Cecchi F, Olivotto I, Camici P
J Clin Med
. 2022 Nov;
11(21).
PMID: 36362787
Myocardial ischemia is an established pathophysiological feature of hypertrophic cardiomyopathy (HCM) that impacts various clinical features, including heart failure (HF) and sudden cardiac death (SCD). The major determinant of myocardial...
16.
Pica S, Crimi G, Castelvecchio S, Pazzanese V, Palmisano A, Lombardi M, et al.
Int J Cardiol
. 2022 Nov;
370:8-17.
PMID: 36351542
Background: Left ventricular (LV) remodelling (REM) ensuing after ST-elevation myocardial infarction (STEMI), has typically been studied by echocardiography, which has limitations, or cardiac magnetic resonance (CMR) in early phase that...
17.
Suda A, Takahashi J, Schwidder M, Ong P, Ang D, Berry C, et al.
Int J Cardiol Heart Vasc
. 2022 Nov;
43:101139.
PMID: 36338319
Methods: In this international prospective cohort study of MVA by the Coronary Vasomotor Disorders International Study (COVADIS) group, we examined the association between plasma NT-proBNP levels and the incidence of...
18.
Pisano A, Le Pera L, Carletti R, Cerbelli B, Pignataro M, Pernazza A, et al.
Microcirculation
. 2022 Oct;
29(8):e12790.
PMID: 36198058
Objective: Coronary microvascular dysfunction (CMD) is a key pathophysiological feature of hypertrophic cardiomyopathy (HCM), contributing to myocardial ischemia and representing a critical determinant of patients' adverse outcome. The molecular mechanisms...
19.
Ammirati E, Raimondi F, Piriou N, Sardo Infirri L, Mohiddin S, Mazzanti A, et al.
JACC Heart Fail
. 2022 Sep;
10(10):714-727.
PMID: 36175056
Background: The risk of adverse cardiovascular events in patients with acute myocarditis (AM) and desmosomal gene variants (DGV) remains unknown. Objectives: The purpose of this study was to ascertain the...
20.
Gulati M, Khan N, George M, Berry C, Chieffo A, Camici P, et al.
Int J Cardiol
. 2022 Sep;
371:28-39.
PMID: 36162521
Background: There is limited information available regarding evidence of ischemia with no obstructive coronary arteries (INOCA) and quality of life. Purpose: To determine associations between INOCA and self-reported physical, social,...